▶ 調査レポート

固形腫瘍用薬剤の世界市場:市場規模・現状・予測

• 英文タイトル:Global Drugs for Solid Tumors Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。固形腫瘍用薬剤の世界市場:市場規模・現状・予測 / Global Drugs for Solid Tumors Market Size, Status and Forecast 2019-2025 / QYR9ST03183資料のイメージです。• レポートコード:QYR9ST03183
• 出版社/出版日:QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、102ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※当調査レポートでは、固形腫瘍用薬剤の世界市場について調査・分析し、固形腫瘍用薬剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(小分子、生物製剤)、用途別(病院、診療所、学術研究機関)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の固形腫瘍用薬剤市場動向
・主要企業別マーケットシェア
・固形腫瘍用薬剤の種類別市場規模2014-2019
(小分子、生物製剤)
・固形腫瘍用薬剤の用途別市場規模2014-2019
(病院、診療所、学術研究機関)
・固形腫瘍用薬剤の北米市場:主要企業・種類別/用途別市場規模
・固形腫瘍用薬剤のヨーロッパ市場:主要企業・種類別/用途別市場規模
・固形腫瘍用薬剤の中国市場:主要企業・種類別/用途別市場規模
・固形腫瘍用薬剤の日本国内市場:主要企業・種類別/用途別市場規模
・固形腫瘍用薬剤の東南アジア市場:主要企業・種類別/用途別市場規模
・固形腫瘍用薬剤のインド市場:主要企業・種類別/用途別市場規模
・固形腫瘍用薬剤の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Hoffmann-La Roche、Novartis、Celgene、Johnson & Johnson、Pfizer、BMS、Eli Lilly、GSK、Merck、Sanofi、AbbVie、AstraZeneca、Bayer、Biogen、Boehringer Ingelheim、Boston Biomedical、Daiichi Sankyo)
・固形腫瘍用薬剤の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...

Solid tumors are an abnormal mass of tissue that do not contain cysts or liquid areas. These may be malignant (cancerous) or benign (not cancerous). They affect bones, organs, and muscles. Based on the type of the cells, solid tumors can be carcinomas, sarcomas, and lymphomas.During 2017, the biologics segment dominated the market and accounted for close to 55% of the market share in terms of revenue. This segment consists of medicinal products extracted from biological sources such as human, animal, microorganisms, or they are manufactured using the latest, cutting-edge biotechnological processes. Biologics include products such as enzymes, blood and blood components, gene therapy, recombinant proteins, somatic cells, tissues, and vaccines.
In terms of geography, the Americas dominated the global solid tumors drugs market. The growth of this market in the Americas is attributed to the increasing uptake of existing biologics drugs and the launch of new biologics. However, the revenue from these drugs will decrease during the forecast period because of the loss of patent exclusivity of drugs, leading to the entry of generics. This decline is expected to be partially offset by favorable reimbursement plans by the government, such as the provision of Medicare and Medicaid. The US is the largest revenue contributor in this region.
In 2018, the global Drugs for Solid Tumors market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Drugs for Solid Tumors status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Drugs for Solid Tumors development in United States, Europe and China.

The key players covered in this study
Hoffmann-La Roche
Novartis
Celgene
Johnson & Johnson
Pfizer
BMS
Eli Lilly
GSK
Merck
Sanofi
AbbVie
AstraZeneca
Bayer
Biogen
Boehringer Ingelheim
Boston Biomedical
Daiichi Sankyo

Market segment by Type, the product can be split into
Small Molecules
Biologics

Market segment by Application, split into
Hospitals
Clinics
Academic and Research Institutes

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Drugs for Solid Tumors status, future forecast, growth opportunity, key market and key players.
To present the Drugs for Solid Tumors development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Drugs for Solid Tumors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Drugs for Solid Tumors Market Size Growth Rate by Type (2014-2025)
1.4.2 Small Molecules
1.4.3 Biologics
1.5 Market by Application
1.5.1 Global Drugs for Solid Tumors Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Academic and Research Institutes
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Drugs for Solid Tumors Market Size
2.2 Drugs for Solid Tumors Growth Trends by Regions
2.2.1 Drugs for Solid Tumors Market Size by Regions (2014-2025)
2.2.2 Drugs for Solid Tumors Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Drugs for Solid Tumors Market Size by Manufacturers
3.1.1 Global Drugs for Solid Tumors Revenue by Manufacturers (2014-2019)
3.1.2 Global Drugs for Solid Tumors Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Drugs for Solid Tumors Market Concentration Ratio (CR5 and HHI)
3.2 Drugs for Solid Tumors Key Players Head office and Area Served
3.3 Key Players Drugs for Solid Tumors Product/Solution/Service
3.4 Date of Enter into Drugs for Solid Tumors Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Drugs for Solid Tumors Market Size by Type (2014-2019)
4.2 Global Drugs for Solid Tumors Market Size by Application (2014-2019)

5 United States
5.1 United States Drugs for Solid Tumors Market Size (2014-2019)
5.2 Drugs for Solid Tumors Key Players in United States
5.3 United States Drugs for Solid Tumors Market Size by Type
5.4 United States Drugs for Solid Tumors Market Size by Application

6 Europe
6.1 Europe Drugs for Solid Tumors Market Size (2014-2019)
6.2 Drugs for Solid Tumors Key Players in Europe
6.3 Europe Drugs for Solid Tumors Market Size by Type
6.4 Europe Drugs for Solid Tumors Market Size by Application

7 China
7.1 China Drugs for Solid Tumors Market Size (2014-2019)
7.2 Drugs for Solid Tumors Key Players in China
7.3 China Drugs for Solid Tumors Market Size by Type
7.4 China Drugs for Solid Tumors Market Size by Application

8 Japan
8.1 Japan Drugs for Solid Tumors Market Size (2014-2019)
8.2 Drugs for Solid Tumors Key Players in Japan
8.3 Japan Drugs for Solid Tumors Market Size by Type
8.4 Japan Drugs for Solid Tumors Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Drugs for Solid Tumors Market Size (2014-2019)
9.2 Drugs for Solid Tumors Key Players in Southeast Asia
9.3 Southeast Asia Drugs for Solid Tumors Market Size by Type
9.4 Southeast Asia Drugs for Solid Tumors Market Size by Application

10 India
10.1 India Drugs for Solid Tumors Market Size (2014-2019)
10.2 Drugs for Solid Tumors Key Players in India
10.3 India Drugs for Solid Tumors Market Size by Type
10.4 India Drugs for Solid Tumors Market Size by Application

11 Central & South America
11.1 Central & South America Drugs for Solid Tumors Market Size (2014-2019)
11.2 Drugs for Solid Tumors Key Players in Central & South America
11.3 Central & South America Drugs for Solid Tumors Market Size by Type
11.4 Central & South America Drugs for Solid Tumors Market Size by Application

12 International Players Profiles
12.1 Hoffmann-La Roche
12.1.1 Hoffmann-La Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Drugs for Solid Tumors Introduction
12.1.4 Hoffmann-La Roche Revenue in Drugs for Solid Tumors Business (2014-2019)
12.1.5 Hoffmann-La Roche Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Drugs for Solid Tumors Introduction
12.2.4 Novartis Revenue in Drugs for Solid Tumors Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Celgene
12.3.1 Celgene Company Details
12.3.2 Company Description and Business Overview
12.3.3 Drugs for Solid Tumors Introduction
12.3.4 Celgene Revenue in Drugs for Solid Tumors Business (2014-2019)
12.3.5 Celgene Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Company Details
12.4.2 Company Description and Business Overview
12.4.3 Drugs for Solid Tumors Introduction
12.4.4 Johnson & Johnson Revenue in Drugs for Solid Tumors Business (2014-2019)
12.4.5 Johnson & Johnson Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Drugs for Solid Tumors Introduction
12.5.4 Pfizer Revenue in Drugs for Solid Tumors Business (2014-2019)
12.5.5 Pfizer Recent Development
12.6 BMS
12.6.1 BMS Company Details
12.6.2 Company Description and Business Overview
12.6.3 Drugs for Solid Tumors Introduction
12.6.4 BMS Revenue in Drugs for Solid Tumors Business (2014-2019)
12.6.5 BMS Recent Development
12.7 Eli Lilly
12.7.1 Eli Lilly Company Details
12.7.2 Company Description and Business Overview
12.7.3 Drugs for Solid Tumors Introduction
12.7.4 Eli Lilly Revenue in Drugs for Solid Tumors Business (2014-2019)
12.7.5 Eli Lilly Recent Development
12.8 GSK
12.8.1 GSK Company Details
12.8.2 Company Description and Business Overview
12.8.3 Drugs for Solid Tumors Introduction
12.8.4 GSK Revenue in Drugs for Solid Tumors Business (2014-2019)
12.8.5 GSK Recent Development
12.9 Merck
12.9.1 Merck Company Details
12.9.2 Company Description and Business Overview
12.9.3 Drugs for Solid Tumors Introduction
12.9.4 Merck Revenue in Drugs for Solid Tumors Business (2014-2019)
12.9.5 Merck Recent Development
12.10 Sanofi
12.10.1 Sanofi Company Details
12.10.2 Company Description and Business Overview
12.10.3 Drugs for Solid Tumors Introduction
12.10.4 Sanofi Revenue in Drugs for Solid Tumors Business (2014-2019)
12.10.5 Sanofi Recent Development
12.11 AbbVie
12.12 AstraZeneca
12.13 Bayer
12.14 Biogen
12.15 Boehringer Ingelheim
12.16 Boston Biomedical
12.17 Daiichi Sankyo

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Drugs for Solid Tumors Key Market Segments
Table Key Players Drugs for Solid Tumors Covered
Table Global Drugs for Solid Tumors Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Drugs for Solid Tumors Market Size Market Share by Type 2014-2025
Figure Small Molecules Figures
Table Key Players of Small Molecules
Figure Biologics Figures
Table Key Players of Biologics
Table Global Drugs for Solid Tumors Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Academic and Research Institutes Case Studies
Figure Drugs for Solid Tumors Report Years Considered
Table Global Drugs for Solid Tumors Market Size 2014-2025 (Million US$)
Figure Global Drugs for Solid Tumors Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Drugs for Solid Tumors Market Size by Regions 2014-2025 (Million US$)
Table Global Drugs for Solid Tumors Market Size by Regions 2014-2019 (Million US$)
Table Global Drugs for Solid Tumors Market Share by Regions 2014-2019
Figure Global Drugs for Solid Tumors Market Share by Regions 2014-2019
Figure Global Drugs for Solid Tumors Market Share by Regions 2019
Table Market Top Trends
Table Global Drugs for Solid Tumors Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Drugs for Solid Tumors Market Share by Manufacturers (2014-2019)
Figure Global Drugs for Solid Tumors Market Share by Manufacturers in 2018
Table Global Drugs for Solid Tumors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Drugs for Solid Tumors Product/Solution/Service
Table Date of Enter into Drugs for Solid Tumors Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Drugs for Solid Tumors Market Size by Type (2014-2019) (Million US$)
Table Global Drugs for Solid Tumors Market Size Share by Type (2014-2019)
Figure Global Drugs for Solid Tumors Market Size Market Share by Type (2014-2019)
Table Global Drugs for Solid Tumors Market Size by Application (2014-2019) (Million US$)
Table Global Drugs for Solid Tumors Market Size Share by Application (2014-2019)
Figure Global Drugs for Solid Tumors Market Size Market Share by Application (2014-2019)
Figure Global Drugs for Solid Tumors Revenue Market Share by Application in 2018
Figure United States Drugs for Solid Tumors Market Size 2014-2019 (Million US$)
Table United States Key Players Drugs for Solid Tumors Revenue (2018-2019) (Million US$)
Table United States Key Players Drugs for Solid Tumors Market Share (2018-2019)
Table United States Drugs for Solid Tumors Market Size by Type (2014-2019) (Million US$)
Table United States Drugs for Solid Tumors Market Share by Type (2014-2019)
Table United States Drugs for Solid Tumors Market Size by Application (2014-2019) (Million US$)
Table United States Drugs for Solid Tumors Market Share by Application (2014-2019)
Figure Europe Drugs for Solid Tumors Market Size 2014-2019 (Million US$)
Table Europe Key Players Drugs for Solid Tumors Revenue (2018-2019) (Million US$)
Table Europe Key Players Drugs for Solid Tumors Market Share (2018-2019)
Table Europe Drugs for Solid Tumors Market Size by Type (2014-2019) (Million US$)
Table Europe Drugs for Solid Tumors Market Share by Type (2014-2019)
Table Europe Drugs for Solid Tumors Market Size by Application (2014-2019) (Million US$)
Table Europe Drugs for Solid Tumors Market Share by Application (2014-2019)
Figure China Drugs for Solid Tumors Market Size 2014-2019 (Million US$)
Table China Key Players Drugs for Solid Tumors Revenue (2018-2019) (Million US$)
Table China Key Players Drugs for Solid Tumors Market Share (2018-2019)
Table China Drugs for Solid Tumors Market Size by Type (2014-20189) (Million US$)
Table China Drugs for Solid Tumors Market Share by Type (2014-2019)
Table China Drugs for Solid Tumors Market Size by Application (2014-2019) (Million US$)
Table China Drugs for Solid Tumors Market Share by Application (2014-2019)
Figure Japan Drugs for Solid Tumors Market Size 2014-2019 (Million US$)
Table Japan Key Players Drugs for Solid Tumors Revenue (2018-2019) (Million US$)
Table Japan Key Players Drugs for Solid Tumors Market Share (2018-2019)
Table Japan Drugs for Solid Tumors Market Size by Type (2014-2019) (Million US$)
Table Japan Drugs for Solid Tumors Market Share by Type (2014-2019)
Table Japan Drugs for Solid Tumors Market Size by Application (2014-2019) (Million US$)
Table Japan Drugs for Solid Tumors Market Share by Application (2014-2019)
Figure Southeast Asia Drugs for Solid Tumors Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Drugs for Solid Tumors Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Drugs for Solid Tumors Market Share (2018-2019)
Table Southeast Asia Drugs for Solid Tumors Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Drugs for Solid Tumors Market Share by Type (2014-2019)
Table Southeast Asia Drugs for Solid Tumors Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Drugs for Solid Tumors Market Share by Application (2014-2019)
Figure India Drugs for Solid Tumors Market Size 2014-2019 (Million US$)
Table India Key Players Drugs for Solid Tumors Revenue (2018-2019) (Million US$)
Table India Key Players Drugs for Solid Tumors Market Share (2018-2019)
Table India Drugs for Solid Tumors Market Size by Type (2014-2019) (Million US$)
Table India Drugs for Solid Tumors Market Share by Type (2014-2019)
Table India Drugs for Solid Tumors Market Size by Application (2014-2019) (Million US$)
Table India Drugs for Solid Tumors Market Share by Application (2014-2019)
Figure Central & South America Drugs for Solid Tumors Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Drugs for Solid Tumors Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Drugs for Solid Tumors Market Share (2018-2019)
Table Central & South America Drugs for Solid Tumors Market Size by Type (2014-2019) (Million US$)
Table Central & South America Drugs for Solid Tumors Market Share by Type (2014-2019)
Table Central & South America Drugs for Solid Tumors Market Size by Application (2014-2019) (Million US$)
Table Central & South America Drugs for Solid Tumors Market Share by Application (2014-2019)
Table Hoffmann-La Roche Company Details
Table Hoffmann-La Roche Revenue in Drugs for Solid Tumors Business (2014-2019) (Million US$)
Figure Hoffmann-La Roche Revenue Growth Rate in Drugs for Solid Tumors Business (2014-2019)
Table Hoffmann-La Roche Recent Development
Table Novartis Company Details
Table Novartis Revenue in Drugs for Solid Tumors Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Drugs for Solid Tumors Business (2014-2019)
Table Novartis Recent Development
Table Celgene Company Details
Table Celgene Revenue in Drugs for Solid Tumors Business (2014-2019)(Million US$)
Figure Celgene Revenue Growth Rate in Drugs for Solid Tumors Business (2014-2019)
Table Celgene Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Drugs for Solid Tumors Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Drugs for Solid Tumors Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Drugs for Solid Tumors Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Drugs for Solid Tumors Business (2014-2019)
Table Pfizer Recent Development
Table BMS Company Details
Table BMS Revenue in Drugs for Solid Tumors Business (2014-2019)(Million US$)
Figure BMS Revenue Growth Rate in Drugs for Solid Tumors Business (2014-2019)
Table BMS Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Drugs for Solid Tumors Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Drugs for Solid Tumors Business (2014-2019)
Table Eli Lilly Recent Development
Table GSK Company Details
Table GSK Revenue in Drugs for Solid Tumors Business (2014-2019)(Million US$)
Figure GSK Revenue Growth Rate in Drugs for Solid Tumors Business (2014-2019)
Table GSK Recent Development
Table Merck Company Details
Table Merck Revenue in Drugs for Solid Tumors Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Drugs for Solid Tumors Business (2014-2019)
Table Merck Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Drugs for Solid Tumors Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Drugs for Solid Tumors Business (2014-2019)
Table Sanofi Recent Development
Table AbbVie Company Details
Table AstraZeneca Company Details
Table Bayer Company Details
Table Biogen Company Details
Table Boehringer Ingelheim Company Details
Table Boston Biomedical Company Details
Table Daiichi Sankyo Company Details
Table Global Drugs for Solid Tumors Market Size by Regions (Million US$) 2019-2025
Figure Global Drugs for Solid Tumors Market Size Share by Regions (2019-2025)
Figure Global Drugs for Solid Tumors Market Size Share by Regions in 2025
Figure United States Drugs for Solid Tumors Market Size Forecast (2019-2025)(Million USD)
Figure Europe Drugs for Solid Tumors Market Size Forecast (2019-2025)(Million USD)
Figure China Drugs for Solid Tumors Market Size Forecast (2019-2025)(Million USD)
Figure Japan Drugs for Solid Tumors Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Drugs for Solid Tumors Market Size Forecast (2019-2025)(Million USD)
Figure India Drugs for Solid Tumors Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Drugs for Solid Tumors Market Size Forecast (2019-2025)(Million USD)
Table Global Drugs for Solid Tumors Market Size by Product (2019-2025) (Million US$)
Figure Global Drugs for Solid Tumors Market Size by Product (2019-2025)
Figure Global Drugs for Solid Tumors Market Size by Product in 2025
Table Global Drugs for Solid Tumors Market Size by Application (2019-2025) (Million US$)
Figure Global Drugs for Solid Tumors Market Size by Application (2019-2025)
Figure Global Drugs for Solid Tumors Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources